Las Vegas, NV -- (SBWIRE) -- 12/12/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Hemispherx BioPharma, Inc (NYSEMKT:HEB), Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB), U.S. Geothermal Inc. (NYSEMKT:HTM), Hanwha Solarone Co Ltd (NASDAQ:HSOL)
Hemispherx BioPharma, Inc (NYSEMKT:HEB) managed to keep its fall at -2.74% on above-normal volume of 2.40M shares. The stock settled at $0.280 after floating in a range of $0.26 to $0.30. Its latest price has reached market capitalization of $46.97 million. Its 52-week range has been $0.18 to $0.75. Hemispherx Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical company engaged in the clinical development of new drugs therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Hemispherx focuses on two core pharmaceutical technology platforms Ampligen and Alferon N Injection.
Has HEB Found The Bottom and Ready To Move Up? Find Out Here
Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) traded down on a volume of 2.33 million, lower than its standard daily volume. Shares have dropped-.049% to $2.04. Over the last twelve months, the stock has gained 9.68% and faced a worst price of $1.11. Navidea Biopharmaceuticals, Inc. (Navidea), formerly Neoprobe Corporation, is a biopharmaceutical company focused on the development and commercialization of precision diagnostic agents. As of December 31, 2011, the Company’s radiopharmaceutical development programs included Lymphoseek (Lymphoseek, Kit for the Preparation of Technetium Tc99m for Injection), a radiopharmaceutical agent for lymph node mapping; AZD4694, an imaging agent, and RIGScan, a tumor antigen-specific targeting agent. In January 2012, the Company executed an option agreement with Alseres Pharmaceuticals.
Has NAVB Found The Bottom And Ready To Gain Momentum? Find Out Here
U.S. Geothermal Inc. (NYSEMKT:HTM) settled 2.63% higher at $0.390 on above-normal volume of 2.22M shares during the last trading day. The stock has its 12-month high at $0.62 and 52-week low price was $0.26. It traded in a range of $0.38 to $0.39 during the last trading day. U.S. Geothermal Inc. (HTM) is engaged in the renewable green energy business. The Company, through its subsidiary, U.S. Geothermal Inc. (Geo-Idaho) are engaged in the acquisition, development and utilization of geothermal resources in the Western Region of the United States.
Why Should Investors Buy HTM After the Recent Fall? Just Go Here and Find Out
In the last trading session, Hanwha Solarone Co Ltd (NASDAQ:HSOL) was down on high volume, trading at a volume of 2.08M versus its average daily volume of 2.03 million shares. At $2.67, the stock has attained market capitalization of 226.09 million. Hanwha SolarOne Co., Ltd. (Hanwha SolarOne) is an integrated manufacturer of silicon ingots, silicon wafers, PV cells and PV modules in China. The Company manufactures a range of silicon ingots, silicon wafers, Photovoltaic (PV) cells and PV modules using advanced manufacturing process technologies that have helped the Company to increase its operational efficiency.
Why Should Investors Buy HSOL After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)